Disease, Illness and Condition Library


    Alzheimer's Disease

    Alzheimer’s disease is a progressive, unrelenting loss of mental function,
    characterized by degeneration of brain tissue, including loss of nerve cells and
    the development of senile plaques and neurofibrillary tangles.

    The most frequent cause of dementia is Alzheimer’s disease. In older people,
    it accounts for up to 65% of dementias. It is very uncommon among people
    younger than 60. It becomes more common with an increase in age. It affects only
    about 1% of people aged 60 to 64, but up to 30% of those seasoned
    citizens older than 85. In the United States, it is estimated that 4 million people
    have Alzheimer’s disease.

    Currently the cause of Alzheimer’s disease is unknown, but genetic factors
    play a role: The disease appears to run in some families and is caused or
    influenced by several specific gene abnormalities. One abnormality affects
    apolipoprotein E (apo E) – the protein part of certain lipoproteins, which
    transports cholesterol through the bloodstream. There are three types of
    apo E (2, 3, and 4). People with the 4 type develop Alzheimer’s disease
    more often and at an earlier age than other people. In contrast, people
    with the 2 type seem to be protected against Alzheimer’s disease.
    People with the 3 type are neither protected nor more prone to develop the
    disease. (These associations have been studies primarily in whites and may
    not apply to other races.) Genetic testing for apo E type cannot determine
    whether a person will develop Alzheimer’s disease. Therefore, this testing
    is not usually recommended.

    In Alzheimer’s disease, parts of the brain degenerate, destroying nerve cells
    and reducing the responsiveness of the remaining nerve cells to many of the
    chemical messengers that transmit signals in the brain (neurotransmitters).
    Abnormalities in brain tissue consist of senile or neuritic plaques (clumps of
    dead nerve cells containing an abnormal, insoluble protein called amyloid)
    and neurofibrillary tangles (twisted strands of insoluble proteins in the nerve
    cell). Such abnormalities develop to some degree in all people as they age
    but are much more numerous in people with Alzheimer’s disease.

    Symptoms

    Dementia resulting from Alzheimer’s disease typically begins subtly.
    People whose disease develops while they are still employed may not perform
    as well in their jobs. In those who are retired and not very active, the changes may
    not be as clear. The first sign may be forgetting recent events, although
    sometimes the disease begins with depression, fears, anxiety, decreased
    emotion, or other personality changes. In the early stages, judgment and
    abstract thinking may be impaired. Speech patterns may change slightly; the
    person may use similar words, use words incorrectly, or be unable to find the
    proper word. An inability to interpret visual cues may make driving a car
    challenging. People with Alzheimer’s disease may be able to function socially
    but may behave oddly. For example, they may forget the name of a recent
    visitor, and their emotions may change unpredictably and rapidly. They may
    get lost on their way to the store.

    As Alzheimer’s disease progresses, people have trouble remembering events
    in the past. They may require help with eating, dressing, bathing, or going to
    the toilet. Wandering, agitation, irritability, hostility, and physical aggression
    are common. All sense of time and place is lost: People with Alzheimer’s
    disease may even get lost on their way to the bathroom at home.
    Their increasing confusion puts them at risk of falling. Psychoses, with
    hallucinations, delusions, and paranoia, develop at some point in about
    50% of people with Alzheimer’s disease.

    Eventually, people with Alzheimer’s disease will have difficulty walking or taking
    care of their personal needs. They may become incontinent and find it difficult
    to swallow, eat, or speak. These changes put them at risk of under nutrition,
    pneumonia, and bedsores (pressure sores). Memory is completely lost.
    Because these people become totally dependent on others, a nursing home
    may become necessary. Ultimately, coma and death, often due to infection,
    result.

    Progression is unpredictable. The expected survival from the time the disorder
    is diagnosed ranges from 2 to 10 years, but frequently it is from 3 to 5 years.
    On average, people with Alzheimer’s disease who can no longer walk live no
    more than 6 years.

    Diagnosis

    Doctors suspect Alzheimer’s disease as the most likely cause of dementia in
    older people whose memory gradually deteriorates. Although a diagnosis based
    on examination of the person can be correct most of the time, the diagnosis of
    Alzheimer’s disease is confirmed only by a microscopic examination of brain
    tissue obtained during an autopsy. When brain tissue is examined, the
    characteristic loss of nerve cells, neurfibrillary tangles, and senile plaques,
    containing amyloid can be seen throughout the brain but most notibly in the
    area of the temporal lobe that is involved in the formation of new memories.
    Analysis of spinal fluid and positron emission tomography (PET) have been
    suggested as ways to diagnose Alzheimer’s disease during life, but these
    procedures are not yet reliable in predicting who will develop Alzheimer’s
    disease  or in identifying people who already have it.

    Treatment

    General measures for treatment of Alzheimer’s disease are the same as for
    all dementias.

    The use of certain drugs (such as nonsteroidal anti-inflammatory drugs
    [NSAIDs]) to prevent and slow the progression of Alzheimer’s disease is under
    study. Estrogen and vitamin E may help prevent and slow progression of the
    disease, although study results are inconsistent. Before any of these
    substances are taken, their risks and benefits should be discussed
    with a doctor.

    Donepezil, rivastigmine, tacrine, and galantamine increase the levels of the
    chemical messenger (neurotransmitter) acetylcholine, which may be low in
    many forms of dementia. These drugs may improve cognitive function for the
    short term but they do not slow the progression of the disease. About 50% of
    the people who have Alzheimer’s disease benefit from these drugs. For these
    people, the drugs effectively turn the clock back 6 to 9 months. These drugs
    are helpful for those with mild to moderate Alzheimer’s disease. Because the
    drugs are expensive and may have side effects, they should not be continued
    in people who do not benefit from them. The most common side effects include
    nausea, vomiting, weight loss, and abdominal pain or cramps. Side effects are
    usually mild and relatively uncommon with donepezil and galantamine.

    An extract of ginkgo biloba (called EGb) has been shown to have effects similar
    to those of the prescription drugs described above but additional research is
    needed to confirm these benefits.

    How Serious is Alzheimer’s Disease?

    Alzheimer’s disease isn’t an acute condition, and it seldom requires emergency
    treatment. Abrupt changes in mental status are usually due to other diseases,
    which may require an immediate evaluation. Alzheimer’s disease, however, is
    ultimately fatal. Individuals with the disease may become bedridden and unable
    to care for themselves. They often die of pneumonia or other infections because
    of the disability. People with Alzheimer’s may become disoriented, increasing
    their risk of falls, which can cause serious fractures or head injures. In the
    elderly, these types of serious falls have been shown to produce quality of
    life issues as well as reducing life expectancy in some cases.

    Alzheimer’s Warning Signs

    When people forget something they often joke that they’re developing
    Alzheimer’s disease. But having Alzheimer’s isn’t the same as having an
    occasional memory lapse. Alzheimer’s is a condition that becomes
    progressively worse. Most people with Alzheimer’s share certain
    characteristics. These may include:

    Increasing and persistent forgetfulness: At its onset, Alzheimer’s disease is
    characterized by periods of forgetfulness, especially of recent events or simple
    directions. But what begins as mild forgetfulness persists and increases. People
    with Alzheimer’s may repeat things and forget conversations or appointments.
    They regularly misplace things, often putting them in illogical locations. They
    frequently forget names, and eventually they may forget the names of family
    members and everyday objects.

    Difficulties with abstract thinking: People with Alzheimer’s disease may initially
    have trouble balancing their checkbook, a problem that progresses to trouble
    understanding and recognizing numbers.

    Difficulty finding the right word: It may be a challenge for individuals with
    Alzheimer’s to find the right words to express their thoughts or even to follow
    conversations. Eventually, reading and writing also are affected.

    Disorientation: People with Alzheimer’s disease may lose track of time and
    dates. They may find themselves lost in familiar surroundings. Eventually, they
    may even wander from home and get lost.

    Loss of judgment: Solving everyday problems, such as knowing what to do if
    food on the stove is burning, becomes increasingly difficult. Alzheimer’s is
    characterized by difficulty doing things that require planning, decision making
    and judgment.

    Difficulty performing familiar tasks: Once routine tasks that require sequential
    steps, such as cooking, become a struggle as the disease progresses. People
    with Alzheimer’s may forget how to do the most basic things, such as brushing
    their teeth.

    Personality changes: Those suffering with this condition may exhibit mood swings.
    They may express distrust in others, show increased stubbornness and withdraw
    socially. Early on, this may be a response to the frustration they feel as they
    notice uncontrollable changes in their memory. Depression often coexists with
    Alzheimer’s disease. Restlessness also is a common sign. As the disease
    progresses, individuals may become anxious or aggressive and behave
    inappropriately.

    General Recommendations (Smart Medicine for Healthier Living)

    * Whatever remedies you use, whither conventional or natural, they will be
    of the greatest benefit if started early, at the first indication of symptoms.

    * Avoid exposure to aluminum. Acid rain has contributed a lot of aluminum
    to tap water. Other everyday sources of aluminum include aluminum cookware,
    canned drinks, some antacids, and antiperspirants.

    * Audio presence intervention has proved helpful for end stage Alzheimer’s
    patients who become so severely agitated that they require tranquilizers or
    restraints to prevent them form hurting themselves. It has been found that
    hearing the recorded voice of a loved one can calm a frustrated and/or violent
    individual more effectively than medication. In this type of treatment, family
    members provide at least four tapes on which they reminisce about happy
    times, talking about the person’s favorite holidays, sing a familiar song, give
    news of the family’s doings, and so on. These one sided conversations are then
    played for the patient through headphones hooked up to a personal tape player.
    According to early reports, the tapes work so well that it has been possible to
    reduce the medication given some patients.

    * Chelation therapy has proven helpful in enhancing cognitive function in many
    Alzheimer’s patients. In chelation therapy, certain agents are administered to
    bind with toxins such as heavy metals and cause the body to excrete them.
    There are oral chelation formulas available over the counter. Intravenous
    chelation employs ethylenediaminetetraacetic acid (EDTA).
    Note: Intravenous chelation therapy must be administered and monitored by a
    qualified doctor. Laboratory rests are required before commencing treatment.
    Because chelation affects the kidneys, kidney function must be monitored
    during the course of the treatment.

    Prevention

    Unfortunately, there is no known way of preventing Alzheimer’s disease.
    Taking therapeutic doses of certain nutrients may help, however.
    Vitamins A, C, and E; the minerals zinc and selenium; the enzyme superoxide
    dismutase (SOD); plus pine bark or grape seed extract and bioflavonoids
    protect against the type of free radical damage that is associated with this
    disease. Magnesium protects against abnormal DNA production, which may
    be involved in the formation of the characteristic neurofibrillary tangles in
    the brain.
    Note: Excessive amounts of Vitamin A can produce serious side effects. Check
    with your doctor or medical professional for appropriate dosage guidelines.

    Sources: Merck Manual of Medical Information
    Mayo Clinic Guide to Family Health
    Healthier Living for Better Health


    Related Natural Alternative Health Products

    MemoRise - Support brain and memory health and prevent common
    forgetfulness associated with normal aging - Continue

    Brain Tonic - Promotes brain health and functioning, including concentration,
    memory and balanced mood in all ages  -  Continue

    Pure Calm - Herbal remedy to soothe common nervous tension and support the
    nervous system. - Continue

    Synaptol - As part of a healthy lifestyle, Synaptol helps support your brain
    and nervous system.  without negative side effects. - Continue
Purchase Remedies
Home
Library Index